Introduction
Vascular endothelial growth factors (VEGFs) and their receptors (VEGFRs) including VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1), and VEGFR-3 (Flt-4) form a regulatory system crucial for normal development and pathological angiogenesis [1] [2] [3] [4] . VEGFRs are structurally related to the Fms/Kit/PDGFR family, and contain an extracellular domain carrying seven immunoglobulin (Ig)-like repeats and a cytoplasmic tyrosine kinase (TK) domain 5, 6 . VEGFR-1 and VEGFR-2 are highly expressed on vascular endothelial cells [7] [8] [9] [10] . We and others have recently shown that VEGFR-1 is expressed not only in vascular endothelial cells but also in monocyte/macrophages 11, 12 , and its signaling is involved in the migration of macrophages toward VEGF-A 13 . In addition to VEGF-A, VEGF-B and
PlGF are also ligands for VEGFR-1, thus, they could play a role in this signaling under both physiological and pathological conditions. Other non-endothelial cells including smooth muscle cells, trophoblasts, and osteoblasts were reported to express VEGFR-1 14 .
Mice lacking Vegfr-2 die in the embryonic stage due to a severe deficiency of vascular development 15 . In contrast, mice lacking Vegfr-1 die due to over-growth and disorganization of the vascular system 16 . Interestingly, however, mouse embryos lacking the TK domain of Vegfr-1 survive without significant defects 17 , suggesting that VEGFR-1 functions as a negative regulator of vascular development by trapping VEGF-A via its ligand-binding domain 14 . Recently, various studies including ours indicated that the expression of VEGFs and VEGFRs is upregulated in various diseases 2, 4, [18] [19] [20] . VEGFR-1-mediated signaling was shown to play a significant role in a variety of pathological conditions such as 19, 21, 22 . VEGFR-1-signaling facilitates tumor angiogenesis and spontaneous lung metastases by inducing the expression of matrix metalloproteinase 9 (MMP-9) [22] [23] [24] . A recent study also showed that VEGFR-1 is important for the reconstitution of hematopoiesis in bone marrow (BM) after irradiation 25 .
Rheumatoid arthritis (RA) 26 is a chronic systemic disease characterized by an inflammatory erosive synovicitis, which shows marked neovascularization, inflammatory cell infiltration, and synovial hyperplasia.
These pathological reactions gradually induce a pannus with inflammatory vascular tissue leading to an irreversible loss of cartilage and bone 27, 28 .
VEGF-A is highly expressed in synovial fluid in RA 29 .
Immunohistochemical and in situ hybridization studies on the synovial tissues have shown that VEGF-A is strongly expressed in synovial macrophages, fibroblasts surrounding microvessels, and vascular smooth muscle cells 29, 30 . In inflamed joints, many cytokines including VEGF and the pro-inflammatory interleukine (IL)-1, IL-6 and Tumor Necrosis
Factor-α (TNFα) play important roles in the pathogenesis of RA 31 .
Iwakura et al. have recently reported that the Human T-cell Leukemia
Virus-1 (HTLV-1) pX transgenic mouse is a useful model for studying RA 32 , in that it is more similar to human RA than other models, such as collagen-antibody-induced arthritis, in terms of chronic progression, the production of rheumatoid factor, and pathological findings 33 . Interesting characteristics of pX transgenic mice include a high incidence of arthritis in the Balb/c genetic background 34 anti-collagen-antibody-induced RA.
In this study, we examined these points using Wild-type and Vegfr-1 tk-deficient mice. We have found that in Vegfr-1 tk-/-mice, the arthritis was significantly suppressed through a decrease in the inflammatory response of monocyte/macrophages and hematopoietic proliferation.
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Materials and Methods

Mice and the Marker-Assisted Selection Protocol (MASP)
All the experiments using animal models were carried out according to the guidelines set by the Animal Center of The Institute of Medical Science, The University of Tokyo. To obtain Vegfr-1 tk -/-mice with the Balb/c background, we backcrossed Vegfr-1 tk +/-heterozygous males (original genetic background is 50% 129SV and 50% C57BL/6) with Balb/c females using MASP (Speed Congenics). First, a total of 60 polymorphic PCR-based microsatellite loci were randomly obtained from Mouse Table 1 ). Two to six markers were set for each chromosome with an average spacing of 20 cM.
At every generation the mouse carrying the fewest C57BL/6 background loci was used for backcrossing. After 4 generations, less than 3% of C57BL/6 background loci were left, and then crosses were made with pX transgenic mice to compare the incidence of arthritis in newly prepared congenic mice with that in the control pX mice. Finally, pX Vegfr-1 tk+/-mice were crossed with Vegfr-1 tk+/-mice for the experiments ( Figure 1B ).
For the pX-induced arthritis, animals were observed every month from age 2 to 6 months and then sacrificed for assessment. Animals were sacrificed for assessment on day7.
Arthritis and histological score
The incidence and severity of arthritis were examined monthly for pX mice, 
Macrophage activities for cytokine secretion and phagocytosis
For the cytokine secretion assay, mouse peritoneal macrophages were For personal use only. on October 31, 2017. by guest www.bloodjournal.org From 9 collected 3 days after the intra-peritoneal injection of 4% thioglycollate.
Peritoneal lavage was collected with 0.5%BSA, 2mM EDTA pH7.2, and PBS, washed twice, and purified using anti-mouse-CD11b MACS (Miltenyi Biotec, Germany). The purity of macrophages was over 90%. 
Colony formation assay
About 1 x 10 5 BMMNCs per 35-mm plate (triplicate) were cultured in complete methylcellulose containing 50ng/ml rmSCF, 10ng/ml rmIL-3, 10ng/ml rhIL-6, and 3U/ml rhEPO (Stem Cell Technologies, Vancouver, Canada). Colonies were scored and phenotyped on an inverted phase microscope 10 days after seeding.
Flow cytometric analysis of bone marrow cells
Mouse BM cells were isolated by flushing the femur BM tissues with 1%
FBS-PBS, and a single cell suspension was obtained. Remaining red blood cells were removed with lysis-buffer (10 mM NH4Cl). BMMNCs were stained with mAbs for Sca-1 (BD Pharmingen, CA) and CD34 (BD Pharmingen), and analyzed using a flow cytometer (Epics-XL, Beckman
Coulter). The instrument was set to collect 2 x 10 4 cells, and these cells were analyzed using FlowJow software (Tree Star Inc). All experiments were performed in triplicate.
Statistical Analysis
An Unpaired Student's t test was used for all analyses. Differences were considered to be statistically significant at p<0.05 and p<0.01. 
Results
Speed
Signals from VEGFR-1 tyrosine kinase contribute to the onset and the progression of arthritis
We measured the incidence and clinical grade of arthritis in the presence or Figure 1B ). The incidence of arthritis, detected as paw swelling, erythema, and ankylosis, was significantly lower in pX Vegfr-1 tk-/-mice than Vegfr-1 wild-type pX transgenic mice at all the stages examined (p<0.072 at 2 to 6 months) (Figure 2A ). In addition, the incidence of arthritis was lower in the heterozygous Vegfr-1 tk+/-mice than pX transgenic wild-type mice before 4 months of age, although the difference was not statistically significant ( Figure 2A ). Clinical scores measured based on redness and swelling of the ankle or wrist were also significantly lower in pX Vegfr-1 tk-/-mice than pX wild-type mice (p<0.058 at 2 to 6 months). Since VEGFR-1 is considered to be associated with angiogenesis, we examined capillary formation in the pannus of synovial tissue. Capillary densities were about 17% lower in pX Vegfr-1 tk-/-mice than pX wild-type mice, however, the difference was not significant (p=0.623) ( Figure 3A-C) .
These results suggest that VEGFR-1 tyrosine kinase-dependent signals contribute to the symptoms of arthritis including pathological findings in a gene-dosage-dependent manner.
For
Production of cytokines by macrophage/monocytes and the function of these cells are important for arthritis
We and others already showed that VEGFR-1 is expressed on monocyte/macrophages 12, 13 and that the VEGF-dependent migration of macrophages is suppressed in Vegfr-1 tk-/-mice 17 . Therefore, we examined local infiltration and the functions of monocyte/macrophages in these mice.
The infiltration of inflammatory cells into arthritic joints was significantly less extensive in pX Vegfr-1 tk-/-mice than in pX wild-type mice ( Figure   2D -F). We also observed using Real-time RT-PCR that angiogenic factors Figure 5E ). KRN951 is a pan-VEGFR inhibitor, however, the arthritic symptoms and histological abnormalities with KRN951 were as mild as those of pX Vegfr-1 tk-deficient mice. Taken together, these results suggest that VEGFR tyrosine kinases, particularly VEGFR-1, contribute to the progression of arthritis.
VEGFR-1 is closely associated with the proliferation/differentiation of hematopoietic cells, but not the number of bone marrow hematopoietic stem cells
Another hallmark of hematopoietic activity is the capacity for colonies to form BMMNCs in vitro 39 . The colony-forming ability of Vegfr-1 tk-/- (Fig. 2, Fig. 5A ),
BMMNCs was reduced to about 70% of that of Wild-type BMMNCs
suggesting that VEGFR-1 signaling is more strongly related to the progression of RA than VEGFR-2 signaling. In addition, the amount of It is of interest that the suppression of chronic RA in the pX mice is dependent on the dosage of the Vegfr-1 tk-gene to some extent. We and others previously showed that the kinase activity of VEGFR-1 is one order of magnitude lower than that of VEGFR-2 45, 46 . These results suggest that the limiting step in the VEGFR-1 signaling pathway to promote RA is not the amount of ligand such as VEGF-A but the amount of VEGFR-1 itself.
They may also support the idea that VEGFR-1 TK activity is a good pharmaceutical target for control of chronic RA.
Several groups including ours have shown that VEGFR-1 is well expressed in monocyte/macrophages at both the mRNA and protein levels 12, 13 , and that VEGFR-1 is important for the VEGF-A-dependent migration of these cells 11, 17 . Therefore, it is reasonable that the infiltration of inflammatory cells was significantly less extensive in Vegfr-1 tk-deficient pX mice than wild-type pX mice ( Figure 2D-F) . Surprisingly, the blocking of the VEGFR-1 signals via deletion of its tyrosine kinase domain clearly suppressed the additional functions of these macrophages
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such as the secretion of IL-6 and VEGF-A stimulated by hVEGF and the phagocytotic reaction to dextran and LPS. The latter phenomenon is particularly interesting since the process of phagocytosis was thought to be a broad/nonspecific reaction against exogenous materials entering the body.
On the other hand, macrophages obtained directly from the abdominal cavity of Vegfr-1 tk-/-mice exhibit similar phagocytotic activity to their wild type counterparts (data not shown). It should be clarified whether the process of phagocytosis is directly dependent on the signaling of VEGFR-1, or the maturation of macrophages to obtain phagocytotic activity is delayed under VEGFR-1 signal-deficient conditions.
A VEGFR TK inhibitor, KRN951, also had suppressive effects on the pX-induced RA mouse model (Fig. 5) . Although the histological scores indicated in Fig. 5C are not statistically significant, the differences in the degree of arthritis more than 18 weeks after birth are significant (Fig. 5B) .
Interestingly, the changes in RA observed between pX and pX/Vegfr-1 tk-/-mice (in Fig. 2F ) were more significant than those in Fig. 5C . To explain these results, we suggest that Vegfr-1 tk-deficient mice lost all signaling from VEGFR-1, whereas the treatment of mice with a VEGFR kinase-inhibitor such as KRN951 is usually incomplete in blocking the kinase activity.
Our results suggest that VEGFR-1 has an effect on the proliferation of HSCs in CFU-B. All of the multi-lineage colonies, i.e. BFU-E, CFU-GM, and CFU-mixed, are suppressed in Vegfr-1 tk-deficient BM HSCs. However, the number of HSCs positive for Sca-1 and CD34 was not so different from that in wild-type mice ( Figure 6C ). There are several potential explanations for these results: (1) Vegfr-1 tk deficiency causes a functional defect in 
